Establishes an awareness campaign on the use of hormone replacement therapy in treating the symptoms of perimenopause and menopause.
Summary
Bill S01720 aims to amend the public health law to establish an awareness campaign regarding hormone replacement therapy (HRT) for treating symptoms associated with perimenopause and menopause. The bill mandates the inclusion of information about the symptoms of these conditions, the potential health risks of HRT, the types of therapies available, and current recommendations for their use. This initiative seeks to educate the public and healthcare providers about the benefits and risks of hormone replacement therapy, thereby improving awareness and informed decision-making among women experiencing these symptoms.
Impact
If enacted, this bill would enhance public health initiatives related to women's health, specifically targeting the demographic affected by perimenopause and menopause. It would require the Department of Health to develop and disseminate educational materials and resources, potentially leading to increased access to information on HRT. This could influence healthcare practices and patient-provider discussions regarding menopause management, impacting how healthcare providers approach treatment options for their patients.
Sentiment
The sentiment surrounding Bill S01720 appears to be overwhelmingly positive, as indicated by the unanimous votes in both the Senate and Assembly. The bill received 59 votes in favor in the Senate and 143 in the Assembly, with no opposition noted. This suggests strong bipartisan support and recognition of the importance of addressing women's health issues related to menopause.
Contention
There were no notable points of contention recorded during the discussions or voting process for this bill. The unanimous support indicates that there were no significant disagreements among lawmakers regarding the necessity or implementation of the awareness campaign on hormone replacement therapy.
State employees; require health benefit plan to cover hormone replacement therapy for biological women experiencing perimenopause and menopause when such therapy is ordered or prescribed
Insurance: health insurers; coverage for treatment of menopause and perimenopause symptoms and waiver of prior authorization for prescription drugs or treatments for menopause and perimenopause symptoms; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406zz.
Insurance: health insurers; coverage for treatment of menopause and perimenopause symptoms and waiver of prior authorization for prescription drugs or treatments for menopause and perimenopause symptoms; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406zz.
Human services: medical services; coverage for treatment of menopause and perimenopause symptoms and waiver of prior authorization for prescription drugs or treatments for menopause and perimenopause symptoms; require. Amends sec. 109h of 1939 PA 280 (MCL 400.109h) & adds sec. 109t.
Human services: medical services; coverage for treatment of menopause and perimenopause symptoms and waiver of prior authorization for prescription drugs or treatments for menopause and perimenopause symptoms; require. Amends sec. 109h of 1939 PA 280 (MCL 400.109h) & adds sec. 109t.
Mandates health insurance coverage for medically necessary hormonal/non-hormonal therapy to treat symptoms of peri-menopause/menopause, if therapy is recommended by qualified healthcare provider licensed in RI and has proven safe and effective.